Home World News FDA Approves Mirdametinib for Adult and Paediatric Patients with NF1 Who Have... World News FDA Approves Mirdametinib for Adult and Paediatric Patients with NF1 Who Have Symptomatic Plexiform Neurofibromas Not Amenable to Complete Resection By Ogkologos - March 20, 2025 930 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the ReNeu study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR A Single Colonoscopy Reduces CRC Risk, but Not CRC Mortality May 11, 2026 Pyrotinib in HER2-mutated Advanced NSCLC Previously Treated with Chemotherapy July 13, 2020 Following Abnormal Cancer Screening Results, Multi-Level Reminders May Increase Follow-Up December 22, 2023 Imaging Test Could Help Guide Breast Cancer Treatment Decisions March 11, 2021 Load more HOT NEWS Beauty, Healing and Space Opdualag Becomes First FDA-Approved Immunotherapy to Target LAG-3 Final DFS Analysis Demonstrates that Adjuvant Osimertinib Improves DFS in Patients... College Basketball Star Plays First Game in Nearly Two Years After...
